The OARSI Clinical Trials Symposium occurred on Wednesday, October 20, 2021T. Nearly 200 attendees learned from OARSI members and individuals from the FDA in a debate that continued previous discussions among OARSI, the FDA, and the Arthritis Foundation. If you missed the symposium or would like to view it again, you can view the recording.
A special thank you to our sponsors: Biosplice, Nordic Bioscience, and Pfizer | Lilly.
Published every Friday, the OARSI Weekly Briefing the single resource you need to stay up to date with OARSI & World Congress news, membership announcements, and happenings within the OARSI & OA community.
November 12, 2021 - Current Briefing
By popular demand, the OARSI Live webinar series will be returning next month. The OARSI Engagement Committee has created an exciting program of monthly presentations, including keynote speakers, journal clubs, and OARSI Discussion Group forums. OARSI Live webinars will typically be scheduled on the third Wednesday of each month and are offered free for OARSI members. Session recordings will be made available on the OARSI website.
The next OARSI Live will be held on Wednesday, December 15 at 9:00 am ET. Tonia Vincent, MD, PhD, will present The importance and implications of mechanoflammation in the pathogenesis of OA.
By Various
~The Pre-Competitive Consortium for Osteoarthritis, an initiative of the Osteoarthritis Research Society International, submitted a White Paper...
Tags: White Paper, Serious Disease, FDA
By Multiple Authors
For the first time, OARSI has developed treatment guidelines tailored to different types of patients with osteoarthritis (OA) of the knee. These...
Tags: Patient Summary, Guidelines, Knee Osteoarthritis
